We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSGS
376
DELISTED
CSG Systems International
CSGS
| $9.91M | 0.01% |
210,151
-1,046
| -0.5% | -$47.6K |
|
377
Madison Square Garden
MSGS
$9.39B
| $9.82M | 0.01% |
56,906
+1,905
| +3% | +$344K |
|
378
NorthWestern Energy
NWE
$4.43B
| $9.76M | 0.01% |
162,017
-865
| -0.5% | -$56.3K |
|
379
Armstrong World Industries
AWI
$7.84B
| $9.53M | 0.01% |
88,886
+9,617
| +12% | +$990K |
|
|
JBTM
380
JBT Marel
JBTM
$6.39B
| $9.43M | 0.01% |
66,145
+603
| +0.9% | +$84.1K |
|
381
Darling Ingredients
DAR
$9.44B
| $9.34M | 0.01% |
138,383
-77,431
| -36% | -$5.45M |
|
382
TriMas Corp
TRS
$1.44B
| $9.34M | 0.01% |
307,794
+1,099
| +0.4% | +$34.9K |
|
383
Spectrum Brands
SPB
$2.07B
| $9.12M | 0.01% |
+107,187
| New | +$9.45M |
|
384
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $8.75M | 0.01% |
315,027
-28,028
| -8% | -$767K |
|
385
ACI Worldwide
ACIW
$5.42B
| $8.74M | 0.01% |
235,465
-12,769
| -5% | -$499K |
|
386
J&J Snack Foods
JJSF
$1.71B
| $8.72M | 0.01% |
50,019
-1,494
| -3% | -$252K |
|
|
OPLN
387
Openlane
OPLN
$4.54B
| $8.21M | 0.01% |
468,070
-1,988
| -0.4% | -$33.7K |
|
388
Vistra
VST
$47.4B
| $8.03M | 0.01% |
432,987
-288,880
| -40% | -$4.99M |
|
|
ECOM
389
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $7.81M | 0.01% |
318,539
+10,540
| +3% | +$253K |
|
390
Alta Equipment Group
ALTG
$245M
| $7.55M | 0.01% |
568,036
+74,024
| +15% | +$1.01M |
|
|
HMHC
391
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $7.42M | 0.01% |
671,771
+2,670
| +0.4% | +$25.1K |
|
392
iShares Russell 1000 Value ETF
IWD
$83.9B
| $6.95M | 0.01% |
43,817
-1,212
| -3% | -$192K |
|
393
Pure Cycle
PCYO
$261M
| $6.84M | 0.01% |
494,960
+4,632
| +0.9% | +$66.2K |
|
394
Ingevity
NGVT
$2.68B
| $6.83M | 0.01% |
83,972
+27,635
| +49% | +$2.22M |
|
395
Goodyear
GT
$1.85B
| $6.71M | 0.01% |
+391,345
| New | +$7.21M |
|
|
KE
396
Kimball Electronics
KE
$628M
| $6.47M | 0.01% |
297,758
+332
| +0.1% | +$7.48K |
|
397
Liberty Latin America Class C
LILAK
$1.64B
| $6.3M | 0.01% |
491,855
-51,596
| -9% | -$662K |
|
398
International Money Express
IMXI
$367M
| $6.15M | 0.01% |
+414,146
| New | +$6.2M |
|
|
VRNT
399
DELISTED
Verint Systems
VRNT
| $6.07M | 0.01% |
134,737
-8,804
| -6% | -$408K |
|
400
Cracker Barrel
CBRL
$1.29B
| $5.93M | 0.01% |
39,931
-196
| -0.5% | -$31.5K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.